1. Introduction {#sec1}
===============

Aging in our cultural setting is a complex of factors leading to disadvantages and potential diseases. Aging as a complex development leading to more knowledge and potential wisdom is widely neglected in the natural sciences. Aging is potentially dangerous and should be prevented if possible---but what does aging in a specific setting mean?

Even though ocular physiology has its primary focus on retinal light perception and transparency of the optic apparatus, a number of functions are known to be located in the choroid including nutrition of the outer retina, fine-tuning of the central fovea (short term during accommodation and long term during eye growth), and buffering of the intraocular temperature. All these conditions are crucial for proper vision and should remain functional throughout life. The present review focuses on the impact of chronologic and biologic aspects on the function of the choroid analysing the published literature. The key questions should clarify which aspects concerning aging are known at present in the human choroid and how can they lead our understanding of this process.

2. Choroidal Thickness {#sec2}
======================

2.1. Data {#sec2.1}
---------

Thinning of the total choroid over age was described in several cross-sectional studies. Morphological postmortem observations revealed a decrease up to 57% (\[[@B58]\] 95 donors, age range 6--100 years; \[[@B61]\] 45 donors, age range 17--84 years). The age-related thinning was also observed using optic coherence tomography in vivo (\[[@B31]\] 43 volunteers, age range 23--88 years; \[[@B45]\] 34 volunteers, age range 22--78 years; \[[@B75]\] 3468 volunteers, age range 50--93 years). One study, however, observed an age-related thinning effect only in myopic eyes (\[[@B14]\] 32 volunteers, age range 19--80 years). Another study revealed differences in choroidal thickness between adult (up to 60 years) and senescent (over 60 years) healthy volunteers (*n* = 210) without a constant age-dependent correlation \[[@B13]\]. No correlation of age and thinning of the human choroid was described more recently (\[[@B26]\] 36 volunteers, age range 28--79 years; \[[@B68]\] 45 volunteers, age range 23--80 years).

2.2. Discussion {#sec2.2}
---------------

For a long time, supported by numerous studies, thinning of the choroid was described as a chronologic aging process. Unfortunately, all studies had a cross-sectional design and they did not differ between subgroups of healthy volunteers (like gender, general health conditions, vision development, or ocular activity). Therefore, the relation to chronologic aging is not as yet verified. A longitudinal study design and a subgroup analysis are necessary for further studies covering this topic.

3. Choroidal Pigmentation {#sec3}
=========================

3.1. Data {#sec3.1}
---------

In vivo, the pigmentation of the posterior eye fundus is a combination of the retinal pigment epithelium (RPE) and the choroidal melanocytes. Fluorescence optical measurements on paraffin sections of 38 donors (aged 2 to 90 years; 19 whites, 16 American blacks) showed a trend of decreasing content with aging in both RPE and choroidal melanocytes \[[@B76]\]. By contrast, biochemical measurements of melanin in the peripheral and macular choroid (11 donors, aged 17--88 years) revealed two-to-threefold higher levels in the macula region compared to the more peripheral regions, but no alteration with aging \[[@B24]\].

3.2. Discussion {#sec3.2}
---------------

It remains to be determined whether melanin decreases physiologically with age. Its importance for normal eye function has been acknowledged for both RPE \[[@B65]\] and choroid \[[@B55]\], and a decrease of melanin has been described in numerous pathologic conditions.

4. Choroidal Vasculature and Blood Flow {#sec4}
=======================================

4.1. Data {#sec4.1}
---------

Early studies on age-related changes of the choroidal vasculature focused on the choriocapillaris and observed a morphologic reduction in the cross-sectional area (\[[@B38]\] 5 donors, ages 3,5 months, 40 and 99 years; Ring and Fujino \[[@B59]\], 125 donors, age range 22nd week of gestation--104 years; Ramrattan et al. \[[@B58]\], 95 donors, age range 6--100 years; Rymgayłło-Jankowska et al. \[[@B61]\], 45 donors, age range 17--84 years). Physiologic blood flow measurements suggested a "linear" reduction of choroidal blood flow (\[[@B19]\] 29 volunteers, age range 15--76 years; \[[@B12]\] 130 volunteers, age range 19--83 years; \[[@B41]\] 118 volunteers, age range 19--75 years) and a reduction of choroidal arterioles and of the capillary filling time in adults over 50 years of age (\[[@B32]\] 30 volunteers, age range 21--81). A gender-biased analysis of choroidal blood flow \[[@B36]\] revealed significant lower levels in older (around 60 years of age; *n* = 11) versus younger females (around 30 years of age; *n* = 16) but not in males (same age groups; *n* = 26).

The endothelial cells of the choroidal vessels showed no age-related changes regarding their cytoarchitecture (\[[@B22]\] 65 donors, age range 7--87 years).

4.2. Discussion {#sec4.2}
---------------

As pointed out already for the choroidal thickness, most of the older studies had a cross-sectional design and did not differ among subgroups of healthy volunteers. Therefore, the relation of chronologic aging and vascular changes (function: reduced blood flow; structure: reduced choriocapillary density) is not as yet verified. Again, a longitudinal study design and a subgroup analysis are necessary for further studies covering this topic. New techniques \[[@B37]\] are on their way to make such studies possible.

5. Choroidal Innervation and Other Single Aspects of Choroidal Tissue {#sec5}
=====================================================================

5.1. Data {#sec5.1}
---------

The complex innervation of the choroid was described using tissue samples of all age groups. The number of neurons within the choroid and the pattern of different neurotransmitters did not change with age (\[[@B46]\] 32 donors, age range 12--95 years). However, only two papers specifically addressed age in their analysis: one described a decrease of adrenergic fibres with less varicosities in four donors aged 70--75 years compared to four patients aged 40--45 years \[[@B53]\]. The other paper investigated the VIP positive nerve fibres in the submacular region of 35 donors between 21 and 93 years of age: within a high interindividual range a statistical decrease could be calculated \[[@B33]\].

A decrease of hyaluronic acid in the choroid stroma was observed, reaching almost complete absence in donors over 50 years of age (\[[@B72]\] 11 donors, age range 28--94 years).

The nonvascular smooth muscle cells in the choroid showed no age-related changes (\[[@B57]\] 19 donors, age range fetal to 94 years).

5.2. Discussion {#sec5.2}
---------------

Single descriptions suggest nerve fibre changes in the aging choroid and in the extracellular composition; these data have to be confirmed.

6. Bruch\'s Membrane {#sec6}
====================

6.1. Data {#sec6.1}
---------

The most widely documented age-related changes of the choroid are in human Bruch\'s membrane and include thickening and changes in their composition (for reviews see \[[@B21], [@B2]\]).

The thickening of Bruch\'s membrane seemed to start in the periphery; in the macular region first thickening was observed from 45 years of age (\[[@B52]\] 31 donors, age range 12 days to 80 years). By some contrast, other groups proposed a linear correlation with age (\[[@B58]\] 95 donors, age range 6--100 years; \[[@B54]\] 88 donors, age range 1--98 years; \[[@B61]\] 45 donors, age range 17--84 years).

Morphological aspects which might represent (at least partly) the thickening of Bruch\'s membrane include an accumulation of lipids, mainly cholesterol (\[[@B67], [@B11]\] 20 donors, age range 17--92 years; \[[@B60]\] 4 donors, aged 27, 41, 76, and 78 years), which seems, however, to persist after the age of 60 years (\[[@B5]\] 27 donors, age range 60--95 years). The amount of type III collagen remained constant during life as did the amount of enzymatically formed collagen cross-links, while noncollagen proteins increased significantly (\[[@B35]\] 9 donors, age range 1--78 years). This is in some contrast to the observations of Newsome, who reported an increase of collagen and elastin in the macula region \[[@B52]\].

Further changes in Bruch\'s membrane include accumulation of glycoconjugates and glycosaminoglycans \[[@B52]\], accumulation of degraded gelatinase (mmp2 and mmp9; \[[@B20]\] 32 donors, age range 17--82 years; \[[@B28]\] 29 donors, age range 21--99 years; \[[@B39]\] 10 donors, age range 21--84 years), timp-3 (\[[@B34]\] 36 donors, age range 14--96 years), pentosidine (\[[@B23]\] 2 donors, 20 months and 82 years of age), AGEs (\[[@B16]\] 8 donors, age range 34--89 years), and nitrotyrosine \[[@B51]\]. In addition, there was a loss of hyaluronic acid with no staining in tissues over 50 years of age (\[[@B72]\] age range 28--94 years).

All mentioned factors might contribute to the decline in the solubility of Bruch\'s membrane (\[[@B35]\] 76 eyes, age range 1--92 years) and to the loss of elasticity (\[[@B73]\] 13 donors, age range 21--97 years). Other functional tests showed decreased diffusion for water (exponential relation; Fisher \[[@B79]\], 12 donor eyes, age range 22--71 years; Moore et al. \[[@B50]\], 13 donors, age range 17--90 years; Starita et al. \[[@B70]\], 12 donor eyes, age range 17--91 years; Starita et al. \[[@B71]\], 26 donors, age range 1--91 years), serum proteins (\[[@B49]\] 17 donors, age range 9--85 years), amino acids (\[[@B29]\] 19 donors, age range 13--89 years), taurine (\[[@B25]\] 29 donors, age range 13--88 years), and macromolecular proteins (\[[@B30]\] 14 donors, age range 4--92 years).

It was shown that the proposed age-related changes of Bruch\'s membrane influenced the gene expression profile of the RPE (\[[@B7]\] 10 donors, age range 31--81 years).

Within Bruch\'s membrane, the appearance of drusen is often seen in adult eyes. Although a correlation between soft drusen but not hard drusen and increase with age was documented (\[[@B10]\] 23 donors, age range 36--94 years), only hard drusen are nowadays considered to be a consequence of normal aging \[[@B2]\]. Randomized screenings observed in eyes of donors older than 40 years a presence of hard drusen in at least 50% of the donors; one study noted no clear age correlation (\[[@B63]\] 202 donors, age range 43--96 years), and the other one noted a tendency of increase with age (\[[@B42]\] 46 donors, age range 42--95 years). A longitudinal study showed that drusen do not necessarily persist over time but show reversibility of over 30% (\[[@B4]\] 483 volunteers, age range at beginning not specified, follow-up after 5 years).

6.2. Discussion {#sec6.2}
---------------

While considering chronologic aging as a factor for changes in Bruch\'s membrane two incisions seem to take place: one is around forty and the other one around sixty. In reevaluating some data proposing linear changes over the whole age range, it becomes apparent that between 40 and 60 years of age some parameters like the diffusion of macromolecules (e.g., \[[@B30]\]) rather show a steady state than a linear constant decrease. Assuming that there is no complete linear chronologic aging in Bruch\'s membrane, three characteristic periods could be hypothesized. The first period (up to 40 years of age) is characterized by a peripheral thickening of Bruch\'s membrane caused by accumulation of lipids, changes in the enzymatic profile of extracellular material regulators, and a subsequent decrease of Bruch\'s membrane solubility and diffusion. The second period (between 40 and 60 years of age) is characterized by thickening of the macular Bruch\'s membrane, further accumulation of lipids, a more frequent presence of drusen, but some lingering of Bruch\'s membrane permeability. The third period (older than 60 years of age) shows no further lipid accumulation but further increase of drusen and decrease of permeability. This last period shows the greatest variability making it difficult to establish age-related aspects in this subgroup.

Even with the greater number of studies, a longitudinal study design is almost not present. Only the Waterman study reported a follow-up of choroidal parameters after 5 years proofing that the morphological appearance of drusen is time sensitive; a clear increase of the number of drusen could not be demonstrated within the five-year period. It is still important to remember that even profound morphological changes are reversible to some extent.

Summarizing the discussions of the different aspects of chronologic age on changes of the choroid mentioned above, it becomes apparent that chronologic aging might not be helpful to understand the "normal" changes and variations of the choroid during time.

Having these difficulties in mind, a more biologic aging was suggested by Sarks characterizing different stages between normal and pathologic conditions. In this study, donor eyes were grouped according to their appearance of Bruch\'s membrane (\[[@B64]\] 216 donors, age range 43--97 years, 6 groups). Although there was some correlation with chronologic age, individual factors of aging were considered as being more important. A second study followed the rules of Sarks (\[[@B27]\] comparing the data of Sarks with a Japanese population) but it did not became a standard for further age-related aspects. The problem with such a grouping is the implicit idea that aging is a prestage of disease and therefore necessary to prevent.

In terms of nonpathological changes of the choroid during life we might follow the ideas of Gerontologist Aubrey Nicholas Jasper De Grey, who pointed to the body\'s basal activity of metabolism leading to some kind of useless end products \[[@B78]\]. Accumulation over time might finally lead to pathological conditions or diseases, depending on the body\'s capability to deal with these often toxic end products. However, if the body changes its strategies or supply, these accumulations are reversible as is aging to a certain degree. De Grey\'s seven damaging events and their transduction to the choroid are as follows.

(1)*Tissue Stiffening*. Two functional aspects lead to the aspects of stability of the choroid---one is the sponge-like character due to the intense vascularisation allowing variation of the total thickness and the other is the elastic counterforce during accommodation. The first aspect is structurally realized by a loosely arranged network of collagen fibres and nonvascular smooth muscle cells. This dynamic system seems to remain fairly constant during chronologic aging \[[@B57], [@B48]\], while collagen thickening and changes in the density and arrangement of the smooth muscle cells can be observed in nonhealthy conditions (e.g., own unpublished observations in glaucomatous eyes). There is a high interindividual variation of a certain subgroup of nonvascular smooth muscle cells around the macular region \[[@B48]\] which has not yet been assigned to certain conditions. The second aspect is supported by elastic fibres within Bruch\'s membrane and the stroma of the choroid (reviewed by \[[@B44]\]). Since elastic fibres cannot be replaced during life, they are structures undergoing irreversible changes with age (e.g., calcification of Bruch\'s membrane elastic fibres; reviewed by \[[@B3]\]). Interestingly, measurements of the elasticity of the choroid showed only mild or no correlation with chronologic aging (\[[@B18], [@B15]\] 8 donors, age range 21--79 years; \[[@B73]\] 13 donors, age range 21--97 years; \[[@B8]\] 24 donors, age range 30--74 years); therefore, some elastic properties not yet specified seem to remain beside the elastic fibres.

\(2\) *Extracellular Debris*. Although the choroid is a highly vascularized tissue, its main capillary bed is the choriocapillaris showing strong interaction to Bruch\'s membrane and the RPE. In addition, the choroid is specific in having no true lymphatic drainage \[[@B66]\]. To cope with this fact, older eyes show numerous debris in the inner sclera which might act as a trash can for the choroid in that respect and explain the loss of scleral permeability with age \[[@B1]\]. Accumulation of extracellular debris towards Bruch\'s membrane also occurs as a general thickening and as the described Drusen formation, which seems to be a temporary effect at the first place \[[@B4]\], showing also some genetic predispositions \[[@B56]\]. With these two borders absorbing and accumulating extracellular debris, the choroid itself remains balanced over a long time concerning its extracellular composition. A completely unknown area is the influence of extraocular conditions like nutrition on debris formation: first loose observations were published for lipids \[[@B5]\] and in an animal model for Zinc \[[@B62]\], but much more effort should be made in this respect.

\(3\) *Intracellular Debris and* (4) *Mitochondrial Defects*. Almost no data exists about intracellular changes of choroidal cells, which include fibrocytes/fibroblasts, melanocytes, immune cells (mainly macrophages and mast cells), and vascular cells (endothelial cells, pericytes, and smooth muscle cells). Melanocytes might change their type of melanin as seen in cell culture experiments \[[@B74]\] and as reviewed for melanocytes in general \[[@B77], [@B69]\]. Macrophages can change their state of activity as seen in early pathology \[[@B9]\]. Mast cells show diversity in the human uvea \[[@B47]\] and some general age-related characteristics (reviewed by \[[@B17]\]). Specific studies for the human choroid do not exist. In contrast, changes in the adjacent human RPE are broadly documented.

\(5\) *Cell Overproliferation*. Since the inner eye has a very strict capacity, proliferation as a tool to cope with metabolic imbalance is negligible. However, looking at conditions considered as pathologic, fibroblasts are able to induce proliferation of endothelial cells and neovascularisation (\[[@B40]--[@B6]\]). This activity is restricted towards Bruch\'s membrane and the RPE.

\(6\) *Cell Loss and* (7) *Cell Death Resistance*. Similar to intracellular changes, almost no data exists about reduced cell densities within the human choroid or the strategies of cells in the choroid to avoid cell death.

In this careful observation of the data concerning age and changes in the choroid it becomes evident that quite a number of factors are hypothesised, but not sufficiently demonstrated yet. To preserve metabolic activity and function, the choroid develops a number of strategies which were touched above but need much more research to establish. Although a number of changes occur frequently correlated with age in the populations studied, we should beware of restricting this data to a linear, irreversible cascade of events leading to pathological conditions. Longitudinal study designs are necessary to further establish the impact of age. Meanwhile, age should not be propagated as an unswayable factor for diseases or predisease conditions. This would help to define more individual strategies for prevention and early stages of a certain defined disease.
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